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Successful infection depends on the ability of the
pathogen to gain nutrients from the host. The
extracellular pathogenic bacterium group A Strepto-
coccus (GAS) causes a vast array of human diseases.
By using the quorum-sensing sil system as a re-
porter, we found that, during adherence to host
cells, GAS delivers streptolysin toxins, creating
endoplasmic reticulum stress. This, in turn, increases
asparagine (ASN) synthetase expression and the
production of ASN. The released ASN is sensed by
the bacteria, altering the expression of 17% of
GAS genes of which about one-third are dependent
on the two-component system TrxSR. The expres-
sion of the streptolysin toxins is strongly upregu-
lated, whereas genes linked to proliferation are
downregulated in ASN absence. Asparaginase, a
widely used chemotherapeutic agent, arrests GAS
growth in human blood and blocks GAS proliferation
in a mouse model of human bacteremia. These re-
sults delineate a pathogenic pathway and propose
a therapeutic strategy against GAS infections.
INTRODUCTION
Pathogens must acquire nutrients from the host throughout the
infectious process, and the presence of specific nutrients at
the beginning of the infection is critical for disease development
(Brown et al., 2008). Group A Streptococcus (GAS) is a strict
human pathogen typically infecting the throat and skin of the
host, causing mild to highly invasive life-threatening infections,
including bacteremia, necrotizing fasciitis (NF), and strepto-
coccal toxic shock syndrome (Carapetis et al., 2005; Cunning-
ham, 2000). In addition, repeated infections with GASmay resultin autoimmune-like diseases (Jackson et al., 2011). Annually,
GAS causes an estimated 700 million cases of mild noninvasive
infections worldwide, of which 650,000 progress to severe
invasive infections with an associated mortality of 25% (Cara-
petis et al., 2005). Although GAS remains sensitive to penicillins,
severe invasive GAS infections are often complicated to treat
and may require supportive care and surgical intervention
(Norrby-Teglund et al., 2005).
Like other pathogens, GAS must adapt and respond to
different nutritional cues within the various hosts’ niches it
faces. Indeed, studies from several laboratories have demon-
strated that GAS regulation of metabolic genes is strongly linked
to the regulation of its virulence functions [for example, see
Chaussee et al., 2004; Kietzman and Caparon, 2011; Kinkel
and McIver, 2008; Malke et al., 2006; Shelburne et al., 2010].
Yet, the fact that GAS is able to directly alter host metabolism
for its own benefit has not been previously reported.
While investigating the conditions under which the quorum-
sensing (QS) locus sil is activated, we discovered that, upon
adherence to mammalian cells, GAS delivers into these cells
streptolysin O (SLO) (Cywes Bentley et al., 2005; Nizet, 2002;
Palmer, 2001) and streptolysin S (SLS) (Datta et al., 2005; Molloy
et al., 2011; Nizet et al., 2000). The delivered toxins generate
endoplasmic reticulum (ER) stress that upregulates the expres-
sion of asparagine synthetase (ASNS) and increases the prod-
uction of asparagine (ASN). The released ASN is sensed by
GAS to alter the expression of nearly 17% of its genes and
also increases the rate of GAS growth.
RESULTS
The Quorum-Sensing Locus sil Is Activated In Vivo
Previously, we identified the QS streptococcal invasion locus (sil)
in the NF GAS strain JS95 (Hidalgo-Grass et al., 2002, 2004)
(termed here JS95ATA). In JS95ATA, the start codon of the autoin-
ducer peptide SilCR is ATA. Thus, this strain is unable to produce
SilCR but is capable of sensing minute concentrations of theCell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc. 97
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Figure 1. sil Is Activated In Vivo
(A) Schematic representation of the sil genes. sil
core contains three polycistronic units: silA/B, TCS
SilA/B; silE/D/CR, ABC transporter system (SilD/E)
(plus the autoinducer peptide SilCR); and blp
bacteriocin-like peptides, including BlpM. Their
transcription is initiated from P1, P3, and P4
promoters, respectively. The transcript of silC is
initiated from the P2 promoter. Promoters induced
and noninduced by SilCR are illustrated by filled
and empty flags, respectively.
(B and C) sil is activated in vivo. Biopsies were
taken 6 hr after subcutaneous inoculation of mice
with JS95ATApP4-gfp or JS95ATGpP4-gfp. Tissue
sections were stained and analyzed by confocal
microscopy (363) for (A) and 310 for (B).
Brackets, hair follicles; empty arrows, bacteria;
filled arrows, bacteria expressing GFP; triangles,
muscle layer; scale bars, 100 mm.
(D) Quantification of sil activation. Mice were
inoculated with JS95ATGpP4-luc or JS95ATApP4-
luc. Punch biopsies were homogenized, and
relative luminescence units (RLU) were normalized
to the CFUs. Each value represents the mean of
two determinations conducted for each punch
biopsy. The highest mean value designated as
100% was obtained for a mouse challenged with
JS95ATGpP4-luc. Horizontal lines, medians. The
probabilities were calculated using Mann-Whitney
U test. Two independent experiments were per-
formed and yielded similar results.peptide through its two-component system (TCS) SilA/B and
can turn on the autoinduction cycle, as depicted in Figure 1A.
By characterizing the promoters that are highly stimulated by
SilCR through SilA/B (Figure 1A), we developed the ability to
quantify SilCR-mediated signaling by measuring GFP or lucif-
erase (Luc) accumulation and identified GAS and group G strep-
tococcal (GGS) strains that preserved the ability to both sense
and produce SilCR (Belotserkovsky et al., 2009). Here, we
changed the start codon of silCR from ATA to ATG and demon-
strated that the resulting strain, JS95ATG, acquired the ability to
produce SilCR when minute quantities of synthetic SilCR were
added to the culture medium and initiated the autoinduction
cycle (Figures 1A and S1A available online). To test whether sil
would be self-activated in vivo, we transformed JS95ATA and
JS95ATG with pP4-gfp or pP4-luc (Figure 1A and Table S2).
The corresponding strains were injected subcutaneously into
mice, and punch biopsies of soft-tissue were taken (Hidalgo-
Grass et al., 2006). GFP-labeled bacteria were detected in
mice injected with JS95ATGpP4-gfp, but not with JS95ATApP4-
gfp (Figures 1B and 1C). Furthermore, GFP expression was
apparent as early as 6 hr after mice injection (Figures 1B and
1C). Only a portion of the bacteria present in the examined
fields was expressing GFP, as evident by comparing GAS
staining by DAPI and GFP (Figures 1B and 1C). To provide a
quantitative measure of sil activation in vivo, infected tissue
samples were collected from mice challenged either with
JS95ATApP4-luc or JS95ATGpP4-luc. Samples were homo-
genized, and Luc activity was determined and normalized to
the number of colony-forming units (CFU). Luc activity in mice
infected with JS95ATGpP4-luc was significantly higher than in98 Cell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc.mice infected with JS95ATApP4-luc (Figure 1D). The activation
was transient and was detected at 6 and 12 hr after inoculation,
but not at 3 and 24 hr (Figure 1D). Taken together, these results
show that the host microenvironment that exists during the initial
stages of GAS infection is suitable for turning on sil naturally.
sil Activation Occurs Ex Vivo during GAS Adherence to
Mammalian Cells
To test that sil activation occurs ex vivo, we infected HeLa cells
with either JS95ATGpP4-gfp or JS95ATApP4-gfp. The infection
was conducted at multiplicity of infection (MOI) of 1.0. At
various time points after infection, samples from the culture
media containing bacteria were withdrawn and subjected to
fluorescence-activated cell sorting (FACS) (Figures S1B and
S1C) or to determination of SilCR production using reporter
strains (Figure S1B). A time-dependent increase in GFP
expression was detected in the medium of HeLa cells infected
with JS95ATGpP4-gfp (Figures 2A and 2C) that peaked at 7 hr
after infection and was detectable even after 22 hr (Figure 2C).
In sharp contrast, no significant activation was detected in
the medium of HeLa cells infected with JS95ATApP4-gfp (Fig-
ure 2B). Subsequent studies showed that the presence of
HeLa cells is absolutely necessary for activation (Figure 2C),
and intact, but not lysed, cells support this process (Figure S2A).
As expected, activation required intact SilA/B (Figure 2C) and
was specifically blocked by SilCR antiserum (Figure S2B). The
process of self-activation was not restricted to HeLa cells but
occurred also when mouse embryonic fibroblasts (MEFs) (Fig-
ures 2E, 3A–3C, 4B, 4C, S2F, and S3A–S3C), L929 cells (Fig-
ure S3D), and Raw 264.7 cells (data not shown) were infected
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Figure 2. Interaction of GASwith Eukaryotic
Cells Is Required for sil Activation
(A and B) FACS analyses of sil activation. HeLa
cells were infected (MOI 1.0) with JS95ATGpP4-
gfp (A) or JS95ATApP4-gfp (B). FACS analyses of
GFP-labeled bacteria were performed at the indi-
cated times as explained in the Experimental
Procedures and Figure S1.
(C) Quantification of sil activation. Infection of
HeLa cells was conducted with the indicated
strains (Table S1). The mean fluorescence in-
tensities (MFIs) were computed from the FACS
analyses for each time point. All values represent
the mean of three determinations ± SD. Two in-
dependent experiments were performed and
yielded similar results (Table S4).
(D) Contact between GAS and HeLa cells facili-
tates sil activation. JS95ATGpP4-gfp was added to
Transwell chambers as indicated. sil activation
was determined by FACS analyses. The values
represent the mean of three determinations ± SD.
Two independent experiments were performed
and yielded similar results (Table S4).
(E) Both SLS and SLO mediate sil activation.
JS95ATG and the specified mutants (Table S1) were
incubated with MEF cells for the indicated time pe-
riods. sil activation was determined by quantifying
the level of SilCR as explained in the Experimental
Procedures and Figure S1B. The fluorescence of
the GFP-labeled reporter strain was normalized
to the number of the bacteria (relative fluorescence).
The values represent the mean of tree determi-
nations ± SD. Two independent experiments were
performed and yielded similar results (Table S4).
(F) Both SLS and SLOmediate sil activation in vivo.
Mice were inoculated with JS95ATGpP4-luc,
JS95ATApP4-luc, or JS95ATGDslo,sagI
pP4-luc.
Punch biopsies were taken 6 hr after injection and
homogenized, and relative luminescence units
(RLU) were normalized to the CFUs. Each value
represents the mean of two determinations con-
ducted for each punch biopsy. The highest mean
value designated as 100% was obtained for a
mouse challenged with JS95ATG. Horizontal lines,
medians. The probabilities were calculated using
Mann-Whitney U test. Two independent experi-
ments were performed and yielded similar results.
See also Figures S1 and S2.with JS95ATGpP4-gfp. To demonstrate that self-activation also
occurs in strains possessing naturally active sil [Table S1 and
(Belotserkovsky et al., 2009)], we transformed GAS and GGS
sil-active isolates with pP4-gfp and then infected MEF cells
with the corresponding strains. Activation occurred in the pres-
ence, but not in the absence, of MEF cells (data not shown)
and was inhibited by the addition of SilCR antiserum, but not
by a control serum (Figure S2C). To demonstrate that self-activa-
tion occurs also in vivo for a strain possessing naturally active
sil, we transformed GAS strain NS144 of emm77-type with
pP4-luc and demonstrated that Luc is produced under the
settings that are described in Figure 1D (Figure S2D).
Although GAS is considered an extracellular pathogen, GAS
adherence to eukaryotic cells may lead to its internalization
(Courtney et al., 2002). To test whether GAS internalizationcontributes to sil activation, we treated HeLa cells with cyto-
chalasin D (Ozeri et al., 2001) and found that, although this treat-
ment reduced the level of intracellular GAS by 200-fold, it did
not affect sil activation (Figure S2E). Next, we tested whether
activation occurs when bacteria and eukaryotic cells are sepa-
rated by a membrane preventing physical contact but allowing
diffusion of small molecules. HeLa cells were grown in a Trans-
well device and infected with JS95ATGpP4-gfp added either to
the upper Transwell chamber (separated from HeLa cells) or to
the lower Transwell chamber (together with HeLa cells). As
expected, addition of GAS to the lower chamber resulted in sil
activation that was apparent after 4 hr and peaked at 7 hr after
infection, and the presence of HeLa cells was necessary for
the activation. However, addition of the bacteria to the upper
chamber significantly delayed sil activation, which was apparentCell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc. 99
between 8 to 10 hr after infection (Figure 2D). These results show
that a physical contact between GAS and HeLa cells facilitates
sil activation, but activation can also occur independently of
direct contact between the cells, probably due to GAS soluble
products.
Contact-dependent activation, followed by contact-indepen-
dent activation, of sil alluded to the possible involvement of
GAS streptolysins because both toxins are more efficiently
delivered into eukaryotic cells during GAS adherence and less
efficiently as soluble products (Ofek et al., 1990; Ruiz et al.,
1998). To test for the involvement of SLS and SLO, we con-
structed mutants of JS95ATG lacking either SLS or SLO and a
double mutant lacking both toxins (Table S1). Whereas the
double mutant lost completely the ability to activate sil upon
contact with MEFs, isogenic mutants of either SLS or SLO
were able to activate sil (Figure 2E). The fact that each toxin
can mediate sil activation independently of the other was exem-
plified by the complementation experiments showing that
expression of either SLO or SLS in the double mutant restored
sil activation (Figure S2F). In the case of the complementing
mutant that expressed SLS from a plasmid, sil activation was
significantly higher than that of JS95ATG (Figure S2F) due to an
increased amount of SLS expression as reflected by measuring
of hemolytic activity (Figure S2G). To verify that the ex vivo acti-
vation of sil shares the same properties as the in vivo one, we
tested the requirement for SLO and SLS in the experimental
settings described in Figure 1D. The results obtained clearly
demonstrated that SLO and SLS significantly contribute to sil
activation under both conditions (Figures 2E and 2F).
Triggering of ER Stress Leads to sil Activation
It was reported that SLOor SLS can participate in GAS-mediated
induction of major cellular responses such as autophagy (Naka-
gawa et al., 2004), necrosis (Miyoshi-Akiyama et al., 2005),
apoptosis (Timmer et al., 2009), oncosis (Goldmann et al.,
2009), and ER stress (Cywes Bentley et al., 2005). Because
staurosporine (STS) induces these responses (Christensen
et al., 1998; Dunai et al., 2012; Short et al., 2007), we tested
whether pretreatment of MEF cells with STS would generate a
conditioned medium capable of activating sil. Indeed, we found
that sil was rapidly and strongly activated by a conditioned
medium generated by treating MEFs with STS (Figure 3A).
To delineate which of the cellular processes mentioned above
is involved in sil activation, we testedwhether MEF cells deficient
of Atg5 (which is essential for GAS-mediated autophagy [Naka-
gawa et al., 2004]) would support sil activation. MEF cells
deficient of Atg5 supported sil activation similarly to Atg5-profi-
cient cells (Figure S3A). Furthermore, the inhibitors of autophagy,
chloroquine, and wortmannin did not inhibit sil activation (Fig-
ure S3B), thus collectively suggesting that autophagy is not
involved in this process. For testing the involvement of
apoptosis, we used the cell-permeable pan-caspase inhibitor,
benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone (Z-VAD),
and found that it did not exert any effect on activation (Fig-
ure S3C). Necroptosis is a specialized pathway of programmed
necrosis that is initiated by ligating death receptors (such as
tumor necrosis factor [TNF] receptor 1) and involves activation
of kinase receptor-interacting proteins, RIP1 and RIP3, under100 Cell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc.caspase-compromised conditions (Vandenabeele et al., 2010).
To test whether necroptosis is linked to sil activation, we used
L929 cells that undergo necroptotic cell death when exposed
to TNFa and Z-VAD (Wu et al., 2011). Treatment of L929 cells
with these compounds led to cell necrosis that was apparent
by microscopic visualization after 2 hr (Figure S3D), yet the
resulting conditioned medium was unable to activate sil
(Figure S3D). Conversely, when the inhibitor of RIP1 kinase,
necrostatin-1 (Nec-1), (Degterev et al., 2008) was included, the
conditioned medium activated sil effectively (Figure S3D).
Because Nec-1 protected L929 cells from necrotic death (Fig-
ure S3D), these results suggested that TNFa causes sil activation
through another route that is hindered by cell necrosis.
It was reported that treatment of L929 cells with TNFa causes
ER stress (Xue et al., 2005). Therefore, we tested whether the
chemical inducers of ER stress thapsigargin (TG) and dithio-
threitol (DTT) would produce conditioned media capable of
activating sil. MEFs treated by these compounds produced
conditioned media that rapidly activated sil (Figure 3B). Further-
more, STS and TG considerably enhanced sil activation when
added to MEFs infected with JS95ATG or even when MEF cells
were infected with the SLO, SLS double mutant (Figure 3C).
This suggested that both STS and TG bypass the requirement
for SLO and SLS in sil activation.
Host asns Transcription Is Upregulated during GAS
Infection of Eukaryotic Cells
The studies of Barbosa-Tessmann et al. (1999) and Gjymishka
et al. (2009) demonstrated that ER stress triggered by TG in
HepG2 cells upregulates the expression of ASNS through the
ATF4 pathway. Because treatment of MEFs with TG generated
a conditioned medium capable of activating sil (Figure 3B), we
examined whether infection of MEF cells with GAS would also
increase the asns transcript level. In an attempt to delay cell
necrosis that may obscure asns transcript determinations, we
lowered FCS concentration in the Dulbecco’s modified Eagle’s
medium (DMEM) to 5%. This decreased the rate of GAS prolifer-
ation and delayed MEF cell necrosis (Figure S4). Infection of
MEFs with JS95ATG under these conditions resulted in increased
asns transcript level compared to uninfected cells or cells in-
fected with the double mutant lacking both SLO and SLS (Fig-
ure 4A, inset). The increase in transcription started to be
apparent after 4 hr and, within 7 to 9 hr, reached 15% to 20%
of that caused by TG (Figure 4A). Nevertheless, asns transcrip-
tion triggered by the double mutant complemented with a
plasmid overexpressing SLS (Figures S2F and S2G) reached a
level of about 50% of that induced by TG (Figure 4A).
To visualize sil activation under the above-described condi-
tions (5% FCS), we analyzed MEF cells infected with JS95ATG
pP4-gfp by fluorescence microscopy. At 4 hr after infection,
few adhering GAS were observed, but no sil activation was
detected (Figure 4B). At 7 hr after infection, many adhering
bacteria were seen, yet only a small fraction of bacteria, which
resided in clumps on some of the infected cells, expressed
GFP (Figure 4B). In contrast, TG that strongly upregulates asns
transcription (Figure 4A) significantly augmented sil activation
when added to MEFs infected with GAS. Already 4 hr after infec-
tion, almost all adhering bacteria produced GFP (Figure 4C). In
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Figure 3. Triggering of ER Stress in
Mammalian Cells Produces a Conditioned
Medium Capable of Activating sil
(A) Treatment of MEF cells with STS. MEF cells
were incubated with or without 0.1 mM STS.
Supernatants were collected and added to
JS95ATGpP4-gfp, and the mixture was further
incubated for 7 hr. sil activation was determined by
FACS analyses, computing themean fluorescence
intensities of GFP-labeled bacteria. The values
represent the mean of three determinations ± SD.
Two independent experiments were performed
and yielded similar results (Table S4).
(B) Treatment of MEF cells with DTT or TG. MEF
cells were incubated with 0.5 mM DTT or 1.0 mM
TG. Then, supernatants were collected and mixed
with JS95ATGpP4-gfp, and sil activation was
determined as in (A). The values shown represent
the mean of three determinations ± SD. Two
independent experiments were performed and
yielded similar results (Table S4).
(C) STS and TG-mediated activation of sil
bypasses the requirement for SLO and SLS. MEF
cells were infected with JS95ATG or with the indi-
cated mutants in the presence and absence of
STS (0.1 mM) (left) or TG (1.0 mM) (right). At the
indicated time points, sil activation was deter-
mined by quantifying the production of SilCR as
conducted in Figure 2E. The values shown repre-
sent the mean of three determinations ± SD. Four
independent experiments (left) and two indepen-
dent experiments (right) were performed and yiel-
ded similar results (Table S4).
See also Figure S3.the absence of TG, a similar level of GFP-producing bacteria
was apparent only after 9 hr of infection (Figure 4B). Because
asns transcription did not change significantly between 7 to
9 hr of GAS infection (Figure 4A, inset) it is conceivable that the
substantial activation of siloccurring between 7 to 9 hr (Figure 4B)
is caused by sil autoinduction.
Asparagine Is Essential for sil Activation and Promotes
Bacterial Proliferation
While testing lung alveolar adenocarcinoma A549 cells for their
ability to facilitate sil activation, we discovered that the nutrient
mixture F-12 (HAM) per se activates sil (Figure 5A). To delineate
the component of F-12 (HAM) that is responsible for sil acti-
vation, we supplemented DMEM with the components that are
present in F-12 (HAM) but are absent in DMEM. Both mediaCell 156, 97–108were supplemented with 10% fetal calf
serum (FCS) that is essential for sil acti-
vation, as well as for GAS growth. We
found that a group of five amino acids
(5AA) containing proline, aspartic acid,
glutamic acid, alanine, and ASN was
accountable for sil activation (Figure 5B).
Although the rate of JS95ATG growth in
DMEM medium fortified with the 4AA
(proline, aspartic acid, glutamic acid,and alanine) was slightly higher than the rate of growth in
DMEM supplemented with ASN alone (Figure S5A), only the
latter supported sil activation (Figure 5C). Nevertheless, when
ASN was added to the medium containing the 4AA, it increased
the rate of JS95ATG growth (Figure S5A) and triggered sil acti-
vation as well (Figure 5C). In an attempt to distinguish between
these two ASN-mediated effects, we progressively increased
the concentration of ASN in DMEM medium supplemented
with the 4AA and monitored both sil activation and bacterial
growth. When the concentration of added ASN was increased
from 0.45 to 0.60mg/l, there was an abrupt increase in sil activity
that peaked at 6 hr after incubation start (Figure S5B). The CFUs
of JS95ATG grown for 6 hr in media containing 0.45 or 0.60 mg/l
ASN were almost identical (Figure S5B), suggesting that sil acti-
vation is triggered by sensing of ASN., January 16, 2014 ª2014 Elsevier Inc. 101
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Figure 4. GAS Upregulates asns Transcrip-
tion in Host Cells
(A) Infection of MEF cells with GAS upregulates
asns transcription. MEF cells in DMEM supple-
mented with 5% FCS were infected with the indi-
cated GAS strains, or TG (1.0 mM) was added.
At the indicated time points, asns transcript level
was determined by real-time RT-PCR and was
normalized to the transcript level of b-actin using
the primers described in Table S3. The real-time
RT-PCR for each sample was performed in
duplicates, and the values shown represent the
means ± SD. Four independent experiments were
performed and yielded similar results (Table S4).
Inset, a zoomed image of the results obtained for
MEF, MEF + JS95ATGDslo,sagI
, and MEF +
JS95ATG.
(B) Visualization of sil activation. MEF cells infected
with JS95ATGpP4-gfp for the indicated time
periods and stained with rhodamine-phalloidin
(red), NucBlue (blue), anti-group A carbohydrate
antibody (orange), and GFP-labeled bacteria
(green). Overlays are presented in the lower right.
Scale bar, 50 mm.
(C) TG enhances sil activation. MEF cells were
incubated with TG (1.0 mM) and, after 0.5 hr, were
infected with JS95ATGpP4-gfp. At the indicated
time points, staining and visualization were per-
formed as in (B).
See also Figure S4.It was reported that, in the chemotaxis receptor McpB of
Bacillus subtilis, the upper PAS domain binds ASN (Glekas
et al., 2010). Protein-BLAST search with the McpB binding
domain for ASN (AA 35 to 279) against all GAS genomes identi-
fied nine TCS with significant but low expected values. All of
these exhibited homology with the sensor kinase YesM of the
Bacillus subtilis TCS YesMN. Subsequent protein-blast of the
12 TCS ofM1T1MGAS5005with YesM identified 3 TCS sensors,
including TrxS (Leday et al., 2008). The protein sequence homol-
ogy between the surface exposed TrxS domain (AA 50 to 283),
and the McpB-binding domain for ASN (AA 35 to 279) exhibited
an insignificant level of global homology (14.2% identity and
27.8% similarity, EMBOSS [Rice et al., 2000]). Nonetheless,
both domains showed a significant level of structural homology
(Figure S5C), as identified by analysis using three different102 Cell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc.programs for protein structure prediction
(Phyre2, I-TASSER, or LOMETS [So¨ding,
2005; Wu and Zhang, 2007; Zhang,
2008]).
To test the possible involvement of
TrxSR in sil regulation, we inactivated
the response regulator trxR by insertion
mutagenesis. The resulting mutant
gained the ability to produce SilCR even
in the absence of ASN in themedium (Fig-
ure 5D). Furthermore, clones that were
cured of the insertional plasmid reverted
to the original phenotype, thus demon-
strating absolute dependence of sil acti-vation on the presence of ASN (Figure 5E). These results, taken
together, suggest that TrxRS activation via ASN releases sil
repression exerted either directly or indirectly. To demonstrate
that ASN-mediated signaling occurs also in vivo, we used the
experimental settings described in Figure 1D and examined
the ability of Kidrolase, a trade name of L-asparginase (ASNase)
(an FDA-approved E. coli enzyme for the treatment of acute
lymphocytic leukemia), to prevent Luc production when injected
together with the bacteria. The results shown in Figure S5D
demonstrate clearly that Kidrolase specifically blocked Luc for-
mation in vivo.
The 10% FCS present in the DMEM medium contains a
residual amount of ASN. To remove ASN completely, we treated
the medium with ASNase, and after that ASNase was heat
inactivated. Complete removal of ASN was verified by
0
40
80
120
160
200
N
on
e
A
ll 
th
e 
re
ag
en
ts
M
gC
l2
N
a2
H
P
O
4
Fe
S
O
4
B
12
py
ru
va
te
Zn
C
l2
C
uS
o4
d-
B
io
tin
A
m
in
o 
ac
id
s
P
ut
ra
ci
n
Th
ym
id
in
e
M
gC
l 2
N
a 2
H
PO
4
Fe
SO
4
Vi
ta
m
in
 B
12
Py
ru
va
te
Zn
C
l 2
C
uS
O
4
M
FI
5A
A
N
o 
ad
di
tio
n
B
Time (h)
0
0.04
0.08
0.12
0.16
0.2
0.24
0.28
0 2 4 6 8 10 12
O
D
60
0
ASN mg/L
15.00
1.500
0.150
0.075
0.050
0.015
0.000
F
0
80
160
240
320
M
FI
A
D
M
EM
D
M
EM
+ 
Si
lC
R
F-
12
(H
AM
)
0.0E+00
3.0E+04
6.0E+04
9.0E+04
1.2E+05
1.5E+05
1 2 3 4 5
R
el
at
iv
e 
flu
or
es
ce
nc
e
- ASN 
+ ASN 
1 2 3
JS95ATGtrxR-
cured clones
E
JS
95
AT
G
JS
95
AT
G
trx
R
-
pu
tre
sc
in
e
0
25
50
75
100
125
0 2 4 6 8
Time (h)
M
FI
C
0.0E+00
3.0E+04
6.0E+04
9.0E+04
1.2E+05
0 2 4 6 8
Time (h)
R
el
at
iv
e 
flu
or
es
ce
nc
e
JS95ATG - ASN 
JS95ATG + ASN 
JS95ATGtrxR- - ASN  
JS95ATGtrxR- + ASN 
D
+ 4AA
No addition
+ 4AA+ASN
+ ASN
Figure 5. ASN Is Essential for sil Activation
and Promotes Bacterial Proliferation
(A) F-12 (HAM) medium supports sil activation.
JS95ATGpP4-gfp was incubated for 6 hr in DMEM
medium, DMEM medium supplemented with
SilCR (5 ng/ml), or in F-12 (HAM) medium. sil
activation was determined by FACS analyses. The
values shown are the mean of three deter-
minations ± SD. Results are representative of two
independent experiments.
(B) 5AA are responsible for sil activation. The
indicated reagents were added to DMEMmedium,
creating final concentrations equal to those
present in the F-12 (HAM) medium. JS95ATGpP4-
gfp was added, and the mixtures were incubated
for 6 hr. sil activation was determined by FACS
analyses. The values shown are the mean of three
determinations ± SD. Results are representative of
two independent experiments.
(C) ASN is essential for sil activation. sil activation
in DMEM medium; DMEM medium supplemented
with 4 amino acids (4AA) [proline (35mg/l), aspartic
acid (13 mg/l), glutamic acid (15 mg/l), and alanine
(9 mg/l)]; with ASN (15 mg/l); or with 4AA plus ASN
was determined by FACS analyses. All values
represent the mean of three determinations ± SD.
Two independent experiments were performed
and yielded similar results (Table S4). (See Fig-
ure S5A for the growth curves under these condi-
tions.)
(D) Inactivation of TrxR leads to constitutive sil
activation. JS95ATGtrxR
 and the parental JS95ATG
strain were incubated in DMEM medium or in
DMEM medium supplemented with 15 mg/l of
ASN. SilCR production was quantified at the
indicated time points as in Figure 3C. All values
represent the mean of three determinations ± SD.
Two independent experiments were performed
and yielded similar results (Table S4).
(E) Plasmid curing of trxR mutants restores the
dependence of sil activation on ASN. The trxR
mutant was cured of the insertion inactivation plasmid (Table S2). JS95ATG, the trxR
mutant, and three cured clones were incubated for 6 hr in DMEMmedium or
in DMEMmedium supplemented with 15 mg/l of ASN. SilCR production was quantified as in Figure 2E. The values shown are the mean of three determinations ±
SD. Results are representative of two independent experiments.
(F) Contribution of ASN to JS95ATG growth in a medium totally depleted of ASN. DMEM medium depleted of ASN (see Experimental Procedures) was supple-
mented with 4AA (see C) andwith the indicated concentrations of ASN. OD600 wasmeasured at the indicated time points. The values shown are themean of three
determinations ± SD. Results are representative of three independent experiments.
See also Figure S5.chromatography-tandemmass spectrometry (see Supplemental
Information and Table S6). JS95ATG growth was significantly
slowed in the absence of ASN even compared to a medium
that was supplemented with ASN concentration as low as
0.015 mg/l ASN. The growth reached its maximal rate at
1.5 mg/l of ASN (Figure 5F). A strong dependence of growth on
ASN was also observed for the pandemic M1T1 GAS clone
(Maamary et al., 2012), albeit the latter grew more rapidly both
in the presence and absence of ASN (Figure S5E). In the absence
of ASN, both GAS strains reached maximal level of growth after
overnight incubation, suggesting that GAS is not auxotrophic for
ASN but produces this AA in DMEM medium at a low rate.
Indeed, the results of transcriptome profiling described below
demonstrate that the transcription of ASNS in GAS is upregu-
lated in the absence of ASN (Table S5, item number 50). Mostfascinating was the finding that, in the absence of added ASN,
growth of both GAS strains was arrested by the addition of
increasing concentrations of ASNase (Figure S5F), suggesting
that even the self-produced ASN could be accessible to the
extracellularly added enzyme.
ASN Sensing Affects the Expression of Nearly 17% of
GAS Genes
In an attempt to identify genes whose response to ASN is
independent of sil, we performed transcriptome profiling of
wild-type (WT) MGAS5005 and of its trxR mutant (which do not
possess sil) using RNA sequencing (RNA-seq). For this purpose,
we grew these strains in DMEM + 10% FCS that was fortified
with the 5AA to early log phase, and then Kidrolase was either
added or not and RNA was harvested at 0.5 and 1.0 hr laterCell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc. 103
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Figure 6. Depletion of ASN Induces Upregu-
lation in the Transcription of SLS and SLO
Encoding Genes
(A–D) Total RNA was isolated from cultures of
JS95ATG and MGAS5005 strains grown in the
absence or presence of Kidrolase as explained in
Experimental Procedures. For JS95ATG and its
isogenic mutant deficient of trxR (TrxR), the
transcription level of sagA (A), sagB (B), sagD (C),
and slo (D) were determined by real-time RT-PCR.
For each gene, the amount of complementary DNA
(cDNA) was normalized to that of gyrA in each RNA
sample. The values shown are the mean ± SD of at
least two independently isolated RNA prepara-
tions analyzed in duplicates. For MGAS5005 and
its isogenic mutant deficient of trxR (TrxR), the
data are derived from RNA-seq (Table S5).
(E) Hypothetical model showing how GAS exploits
host ASN metabolism for its own benefit (see
Results for details).
See also Figure S6.and subjected to RNA-seq analysis. Here, we discuss only the
0.5 hr results, and a more comprehensive analysis will be sub-
mitted soon. Comparison of transcriptome profiles in the pres-
ence and absence of kidrolase in the WT MGAS5005 strain
showed that 311 genes (16.7%) were significantly altered. Out
of the 311 genes, 194 genes (10.4%) were significantly altered
also in the trxR mutant in the presence and absence of Kidro-
lase. 117 genes were significantly altered only in the WT and
not in the trxR mutant; thus, TrxSR is involved in regulating
the transcription of about one-third of the genes that respond
to ASN depletion. Cluster analysis of differential expression of
MGAS5005 and its isogenic TrxR mutant in the presence and
absence of ASN is shown in Figure S6A. The list of the 311 genes104 Cell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc.(Table S5) on which the analysis was
performed contains gene products
involved in metabolism, virulence, gene
regulation, replication, and other func-
tions. To examine whether similar genes
would be affected upon ASN depletion
in the strain JS95ATG, we grew and har-
vested RNA under the same conditions
described for the strain MGAS5005. We
chose to examine the transcription of 12
genes using real-time RT-PCR. As shown
in Table S5, expression of all 12 JS95ATG
genes were comparable to the corre-
sponding genes in MGAS5005 with
respect to ASN depletion, albeit the influ-
ence of TrxR varied for some genes
(Table S5). As expected from the absolute
dependence of sil activation on ASN and
its repression by TrxR (Figure 5E), the
transcription of silE and blpM (Belotser-
kovsky et al., 2009) was strongly up-
regulated in the trxR mutant both in the
presence and absence of ASN (FiguresS6B and S6C). Most intriguing was the finding that the transcrip-
tion of the genes encoding SLO (slo) and SLS (sagA-I operon)
was strongly upregulated in the absence of ASN both in
MGAS5005 and in JS95ATG, yet inMGAS5005, their dependency
on TrxR was less pronounced compared to that in JS95ATG (Fig-
ures 6A–6D). This finding suggests that, in the absence of ASN,
the bacterium increases the production of SLO and SLS to gain
more ASN from the host. Finally, the transcription of genes
involved in GAS replication such as polA, lig, and others (see Ta-
ble S5) were significantly downregulated in the absence of ASN,
suggesting that there is a tight linkage between ASN sensing and
GAS proliferation. Taken together, the results shown are consis-
tent with a model whereby the delivery of SLO and SLS through
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(A) ASNase arrests growth in human blood. Ability
of JS95ATG to grow in nonimmune human blood
was quantified in the absence and presence of
ASNase (Kidrolase 4.0 I.U ml). Bacterial growth
(multiplication factor, MF) represents the increase
in titer during 3 hr of incubation. The values shown
are the mean ± SD of two independent experi-
ments performed on blood withdrawn from two
donors; each experiment was performed in dupli-
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(B) ASNase protects mice against GAS bacter-
emia. Survival rate of mice (n = 7 per group) after
intravenous inoculation with GAS strain JS95ATG
only or with additional 1 or 2 intravenous injections
of ASNase (Kidrolase 200 I.U per mouse). The Kaplan-Meier analysis showed a significant difference in the rate of death of the group receiving GAS only
compared to that receiving GAS and two consecutive injections of ASNase. p = 0.0283; log rank (Mantel-Cox) test. p = 0.015; log rank (Mantel-Cox) test was
obtained for an additional separate experiment.
See also Figure S7.adhering GAS induces ER stress. This in turn results in ASN pro-
duction. The released ASN is sensed byGAS via TrxSR and other
yet unidentified system(s) to both alter the expression of nearly
17% of GAS genes and to accelerate the GAS rate of multiplica-
tion (Figure 6E).
The Therapeutic Effect of ASNase against GAS
Bacteremia
The fact that ASN is required for optimal growth of GAS
(Figures 5F and S5E) and that ASNase blocks GAS growth in
DMEM medium (Figure S5F) suggested that the latter may
prevent the ability of GAS to proliferate in human blood, a
property that is the hallmark for GAS virulence (Cunningham,
2000). In a classical GAS blood survival assay, addition of
Kidrolase at time 0, 0.5, or even 1.0 hr after infection prevented
JS95ATG proliferation (Figure 7A). Similar results were obtained
for the pandemic M1T1 MGAS5005 strain (Figure S7A). To rule
out that the Kidrolase-mediated arrest of GAS proliferation re-
sults from adverse reaction of Kidrolase on phagocytic killing,
which is independent of breakdown of ASN to aspartic acid
and ammonia, we tested the ability of Staphylococcus epider-
midis ATCC 12228 to survive in human blood in the presence
and absence of Kidrolase. We found that S. epidermidis grew
at the same rate in DMEM medium in the presence and
absence of Kidrolase, and its survival rate in whole human
blood was unaffected by the drug, thus ruling out the possibility
that the latter adversely affects bacterial phagocytic killing
(Figure S7B).
To test the ability of Kidrolase to control GAS bacteremia,
we employed the bacteremia mouse model developed by
Medina et al. (2001) and injected mice intravenously (i.v.) with
107 CFU of JS95ATG with or without Kidrolase. All mice that
received two consecutive (24 hr apart) injections of Kidrolase,
but no GAS, survived (Figure 7B). Six out of 7 mice that received
only GAS died within 10 days (Figure 7B). In the group of mice
that received GAS and a single injection of Kidrolase, three out
of seven mice died at days 4 to 5 after GAS injection. No sig-
nificant difference in the death rates of this group and the group
receiving only GAS was observed (p = 0.168, log rank (Mental-
Cox). However, in the group of mice that received GAS andtwo consecutive injections of Kidrolase, three mice died be-
tween days 8 and 9 (Figure 7B). The Kaplan-Meier analysis
showed that there is a significant difference in death rates
between this group and the group of mice receiving GAS only
(p = 0.0283, log rank [Mental-Cox]).
DISCUSSION
In this study, we report that GAS induces the formation of
ASN in the host that is used subsequently by GAS for sensing
and proliferation. It was previously reported that extracellular
GAS dysregulates intracellular calcium in human keratinocytes
due to SLO-mediated membrane damage. This causes ER
stress leading to mitochondrial depolarization and apoptosis
that is followed by cell desquamation and loss of epithelial
integrity (Cywes Bentley et al., 2005). Here, we were able
to disengage these events and show that ER stress triggered
by the delivery of SLO and SLS via the adhering GAS is a
distinct step in the above-mentioned chain of cellular events
that creates a microenvironment promoting GAS sensing and
growth. We took advantage of our finding that sil is activated
by ASN and utilized activation of sil as a reporter for charac-
terization of the sensing process. This enabled us to show
that ASN induction and release from infected cells occurs at
a very early stage of the infectious process, and it is transient
and probably local. Activation of sil is enhanced by GAS ad-
herence, which is considered to be an initial and necessary
step in GAS pathogenesis (Courtney et al., 2002; Cunningham,
2000). Ex vivo sil activation starts to be apparent already 4 hr
after infection and occurs at very low MOI, resembling the
conditions occurring in a human infection. At higher MOI, sil
activation is obliterated due to massive cell necrosis. Moreover,
activation of sil in the murine model of human soft tissue infec-
tion is only apparent between 6 and 12 hr after injection and
occurs in a small portion of the bacterial population. Further-
more, visualization of sil activation on MEFs starts to be
apparent only in a small portion of cells that harbor adhering
bacteria (Figure 4B), whereas the addition of an ER-stress-
inducing agent expands sil activation to almost all adhering
bacteria (Figure 4C).Cell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc. 105
Because sil exists only in a small number of GAS strains and is
not functional in many clinical isolates, we sought to examine
whether or not the ASN-mediated gene regulation is restricted
to sil possessing strains or whether it exists also for sil-deficient
ones. The transcription profiling conducted using RNA-seq for
the sil-deficient M1T1 strain MGAS5005 clearly demonstrates
that sensing of ASN by GAS is a central trait affecting nearly
17% of GAS genes. The fact that ASN deficiency increases the
expression of SLO and SLS genes that constitute the apparatus
of GAS, through which it gains ASN from the host, suggests that
sensing of ASN by GAS plays a central role in the host-pathogen
relationship. This notion is further supported by the fact that
depletion of ASN decreases the rate of GAS growth (Figures
5F and S5E), as well as the expression of genes linked to GAS
replication (Table S5). The fact that part of the ASN sensing is
mediated by the TrxSR TCS, which modulates the transcription
of virulence andmetabolic genes (Leday et al., 2008), further em-
phasizes the importance of this attribute to GAS pathogenesis.
The ability to alter host metabolism for the benefit of a bacterial
pathogen was also shown for the Gram-negative bacterium
Agrobacterium tumefaciens. This pathogen induces plant cells
to synthesize opines upon their transformation with the bacterial
T-DNA plasmid. Opines are preferentially catabolized by
A. tumefaciens and trigger the production of the QS signal
acyl-homoserine lactone (White and Winans, 2007). Because
Staphylococcus aureus, Listeria monocytogenes, and Clos-
tridium botulinium possess SLS- (Molloy et al., 2011) and SLO-
like toxins (Palmer, 2001), it will be interesting to examine
whether these pathogens use a similar strategy as GAS to alter
host metabolism for their own benefit.
ASNase is a major component of therapy for acute lym-
phoblastic leukemia and has been used for more than 40 years
(Pui et al., 2008). Because bacteremia without an identified focus
is the most frequent clinical manifestation of highly invasive GAS
infections (Lepoutre et al., 2011; Lin et al., 2011), we tested
whether ASNase would arrest GAS growth in human blood and
in a murine model of human bacteremia. The ability of ASNase
to prevent GAS growth in both settings suggests the potential
use of ASNase as a therapeutic agent against this important
human pathogen. In summary, our study identifies a host-path-
ogen interaction, which might be exploited for development of
an effective anti-GAS treatment.
EXPERIMENTAL PROCEDURES
Streptococcal Infection of Mice, Blood, and Mammalian Cells
Streptococcal strains, mutants, and variants used in this study, construction
of mutants, and DNA manipulations and primers are described in Tables S1,
S2, and S3. For the murine models of human GAS soft tissue and bacteremia
infections, GAS strains were cultured overnight in Todd-Hewitt medium
supplemented with 0.2% yeast extract (THY). Overnight cultures were diluted
1:20 and grown in THY to mid-log phase (OD600 of 0.3–0.5), washed, and
resuspended in PBS (Biological Industries). For soft tissue infection,
10 g BALB/c female mice (Harlan Laboratories) were injected under the skin
with 1 3 108 CFU of GAS in 100 ml, as previously described by us (Hidalgo-
Grass et al., 2004, 2006). sil activation was visualized by fluorescence of
GFP or determined by luminescence of firefly luciferase (see Supplemental
Information). For the bacteremia model, 100 ml of GAS containing 3 3 107
CFU were injected via to the lateral tail vein of 7-week-old BALB/c male
mice (Harlan Laboratories). 200 international units (I.U.) of Kidrolase (EUSA106 Cell 156, 97–108, January 16, 2014 ª2014 Elsevier Inc.Pharma S.A.) in 50 ml PBS were injected either once, together with the bacteria
at time 0, or once more 24 hr after the first injection. The control group of mice
received two injections of Kidrolase (200 I.U. in 150 ml PBS) only, as described
above. The Institutional Ethics Committee for animal care approved all animal
procedures (approval number MD-10-12267-4).
The ability of GAS to survive in human blood was tested by the direct bacte-
ricidal test of Lancefield as described by us previously (Moses et al., 1997) with
minor modifications. In brief, GAS was grown for 4 hr and adjusted to OD600 of
0.16 in DMEM medium + 5AA and then diluted 1:40,000 into fresh DMEM
medium + 5AA. 0.2 ml containing 300–700 CFU was mixed with 0.6 ml of
freshly drawn heparinized human blood. 4.0 I.U. of Kidrolase were added to
the assay as indicated, and the number of CFU after 3 hr was enumerated.
Multiplication factor was calculated by dividing the CFU at the end of the assay
by the CFU at time 0. S. epidermidis blood survival was conducted as
described before (Moses et al., 1997) with blood that was pretreated with
Kidrolase (40 I.U./ml) 1 hr prior to addition of the bacterium.
Mammalian cells were cultured in DMEM medium in 24-well plates (Nunc)
at 37C in a 5% CO2 incubator. Bacteria were grown in THY to early log phase
(OD600 = 0.3–0.4), washed in PBS by centrifugation, concentrated to an OD600
of 8 (109 CFU/ml), and finally diluted to form a bacterial suspension containing
250,000 CFU in 25 ml of PBS. Prior to infection, the mammalian cells were
washed with PBS and then incubated in fresh DMEM medium into which the
bacterial suspension was added, generating MOI of –1. Plates were then
centrifuged at 300 3 g for 5 min and further incubated at 37C in a CO2
incubator.
Determination of sil Activation
sil activation was quantified by the ‘‘Jump Start’’ assay in which the autoinduc-
tion cycle of native SilCR production (Figure 1A) is initiated by the addition of a
minute quantity of synthetic SilCR (Belotserkovsky et al., 2009). For measuring
sil self-activation, a direct and an indirect assay were designed (Figure S1B).
The direct assay was performed in 24-well plates (Nunc) at 37C in a 5%
CO2 incubator. GAS and GGS strains, harboring the pP4-gfp plasmid, were
grown and resuspended in PBS to 250,000 CFU in 25 ml (see above). These
suspensions were used to infect mammalian cells, mixed with 1ml of mamma-
lian cell conditioned media, or added into 1 ml of DMEM medium supple-
mented with various AA. At the desired times, samples of 1 ml were washed
by centrifugation and resuspended in 1 ml PBS, filtered through a 35 mm nylon
mesh, and subjected to FACS analysis with CYANADP FACS (Dako). The gating
of the forward scatter (FSC) and side scatter (SSC) were set to detect nonag-
gregated GAS or GGS bacteria free of mammalian cells or cell debris (Fig-
ure S1C). This gating was identified using a pure GAS suspension that was
briefly sonicated at low frequency with Transsonic T 460/H (Elma). Excitation
of GFP was conducted with 488 nm laser, and fluorescence was detected
through 530/40 nm FL1 filter. For each sample, 50,000 events were gated,
and the arithmetic mean of fluorescence intensity, along the logarithmic scale,
was computed from histograms like those shown in Figures 2A and 2B using
Summit V4.3 Build 2445 software (Dako).
The indirect assay assesses sil self-activation by quantifying SilCR produc-
tion using the reporter strains JS95ATApP4-gfp or JS95ATAsilE
pP4-gfp (Erm
resistant). This assay was mainly used when the tested strains contained
two antibiotic resistance genes or an Erm-resistant cassette that hampered
the transformation with pP4-gfp or affected the rate of bacterial growth. Tested
strains were grown as described for the direct assay and used to infect
mammalian cells or were seeded in DMEM media containing AA. Then,
0.2 ml from the respective culture media, free of mammalian cells and of
bacteria, were mixed with 0.8 ml of the reporter strains (grown overnight in
THY and diluted 1:25 into a fresh THY medium). The mixtures were incubated
for 2 hr at 37C without agitation in sealed Eppendorf tubes. Reporter strains
were washed by centrifugation and resuspended in 0.6 ml PBS, and samples
of 0.3 ml were transferred into 96-well flat bottom transparent plates (Fluoro-
Nunc). The fluorescence intensity of GFP was measured with Infinite F200
(Tecan, Austria GmbH) using the filter sets 485/20 nm for excitation and 535/
25 nm for emission. The fluorescence data were normalized according to
the density of the cultures, which was determined by measuring OD595. The
relative fluorescence values shown reflect the amount of SilCR present in
the culture medium of the tested strains (Belotserkovsky et al., 2009).
Depletion of ASN
DMEM containing 10% FCS was incubated with E. coli L-ASNase 0.15
units/ml (Sigma) at 37C for 2 hr and inactivated by heating (1 hr at 80C).
ASN depletion was confirmed by chromatography-tandem mass spectrom-
etry (Supplemental Information).
Statistics
All values are expressed as means ± SD. Statistical analysis was performed
as explained in Supplemental Information. For statistical analysis, please refer
to Table S4.
ACCESSION NUMBERS
The data of the RNA-seq were deposited in the SRA Bioproject under ID
PRJNA218856 (see the Extended Experimental Procedures for more
information).
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